JTE‐522, a selective COX‐2 inhibitor, interferes with the growth of lung metastases from colorectal cancer in rats due to inhibition of neovascularization: A vascular cast model study

International Journal of Cancer - Tập 112 Số 6 - Trang 920-926 - 2004
Hirotoshi Kobayashi1, Tsuyoshi Gonda, Hiroyuki Uetake, Tetsuro Higuchi, Masayuki Enomoto, Kenichi Sugihara
1Department of Surgical Oncology, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan. [email protected]

Tóm tắt

AbstractThe lung is a frequent site of metastasis from colorectal cancer, but angiogenesis of lung metastases has not been clarified. Some COX‐2 inhibitors prevent tumor growth, although the inhibitory mechanism at the metastatic site is obscure. We investigated the microvascular structure of small lung metastases and the effect of JTE‐522, a selective COX‐2 inhibitor, on the angiogenesis of pulmonary metastases from colorectal cancer in rats. The tail veins of 25 male F344/DuCrj rats, aged 5 weeks, were injected with a tumor suspension containing 5 × 106 RCN‐9, a rat colon cancer cell line. Three weeks later, pulmonary vascular resin corrosion casts were taken and the vascularity of metastases was studied using stereo and scanning electron microscopes. We investigated the effect of 0, 10 and 30 mg/kg/day of JTE‐522 on the angiogenesis of pulmonary metastases in 3 groups of 5 male rats out of 25. JTE‐522 reduced the diameter of tumor vessels as well as the number and size of metastatic tumors. The diameter of tumor vessels and the size of lung metastases significantly and positively correlated with neovascularization in the control group, but not in the JTE‐522‐treated groups. JTE‐522 also affected type of vasculature of metastases, which differed depending on their size. JTE‐522 interfered with the growth of hematogenous metastatic tumors by disrupting neovascularization. However, JTE‐522 may have some important mechanisms other than inhibition of neovascularization. JTE‐522 may be one of the therapeutic agents for the treatment of hematogenous metastasis of colorectal cancer. © 2004 Wiley‐Liss, Inc.

Từ khóa


Tài liệu tham khảo

10.1007/BF00308631

Folkman J, 1986, How is blood vessel growth regulated in normal and neoplastic tissue?, Cancer Res, 46, 467

10.1007/BF00046358

Liotta LA, 1974, Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation, Cancer Res, 34, 997

10.1016/0304-419X(90)90014-R

10.1016/0304-419X(89)90004-8

10.1002/1097-0142(1950)3:1<74::AID-CNCR2820030111>3.0.CO;2-7

10.1002/path.1711500308

10.1007/BF02237364

10.1016/S0168-8278(87)80078-8

10.1006/jsre.2000.5978

10.1002/jso.2930240119

10.1016/S0021-9258(18)52976-8

Williams CS, 1996, Prostaglandin endoperoxide synthase: why two isoforms?, Am J Physiol, 270, G393

10.1016/0016-5085(94)90246-1

10.1016/S0092-8674(00)81433-6

Swamy MV, 2003, Inhibition of COX‐2 in colon cancer cell lines by celecoxib increases the nuclear localization of active p53, Cancer Res, 63, 5239

10.1073/pnas.94.7.3336

10.1038/sj.bjc.6694262

10.1111/j.1349-7006.1991.tb01751.x

10.1007/s000110050225

10.1679/aohc1950.32.445

10.1007/978-1-4615-3488-4_10

10.1148/84.6.1043

10.1148/84.6.1033

10.1148/85.2.205

10.1148/83.5.830

Viamonte M, 1965, Angiographic evaluation of lung neoplasms, Radiol Clin North Am, 3, 529, 10.1016/S0033-8389(22)02847-0

10.1097/00005382-198710000-00005

10.1007/s005950200148

Reddy BS, 1996, Evaluation of cyclooxygenase‐2 inhibitor for potential chemopreventive properties in colon carcinogenesis, Cancer Res, 56, 4566

10.1016/S0092-8674(00)81988-1

Fujita T, 1998, Size‐ and invasion‐dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas, Cancer Res, 58, 4823

10.1016/S0959-8049(01)00137-X

10.1007/s10350-004-6658-2

Kawamori K, 1998, Chemopreventive activity of celecoxib, a specific cyclooxygenase‐2 inhibitor, against colon carcinogenesis, Cancer Res, 58, 409

Jacoby RF, 2000, The cyclooxygenase‐2 inhibitor celecoxib is a potent preventive and therapeutic agent in the Min mouse model of adenomatous polyposis, Cancer Res, 60, 5040

Oshima M, 2001, Chemoprevention of intestinal polyposis in ApcΔ716 mouse by rofecoxib, a specific cyclooxygenase‐2 inhibitor, Cancer Res, 61, 1733

Masferrer JL, 2000, Antiangiogenic and antitumor activities of cyclooxygenase‐2 inhibitors, Cancer Res, 60, 1306

10.1038/sj.onc.1203286

10.1097/01.LAB.0000090159.53224.B9

10.1002/bjs.4447

Sun Y, 2002, Cyclooxygenase‐2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c‐dependent apoptotic pathway in human colon cancer cells, Cancer Res, 62, 6323

10.1002/ijc.10508

10.1016/S0304-3835(03)00477-4

Kakiuchi Y, 2002, Cyclooxygenase‐2 activity altered the cell‐surface carbohydrate antigens on colon cancer cells and enhanced liver metastasis, Cancer Res, 62, 1567

Thông tin
Thông tin xuất bản

International Journal of Cancer

Tập 112 Số 6

920-926

Thông tin tác giả